We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Esophageal Motility and Airway Defenses Among Infants

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00062452
First Posted: June 6, 2003
Last Update Posted: October 6, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Children's Research Institute
Information provided by (Responsible Party):
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  Purpose
Feeding difficulties and airway related consequences contribute significantly to the infant mortality and morbidity. Some of these problems may be dependent on neural control and muscular function. Prematurity, congenital anomalies and perinatal depression represent three important conditions in infants, that may have feeding and airway difficulties.Development of motility of the foregut and the adaptation during normal and disease in developing infants is unclear.

Condition
Infant, Premature, Diseases Congenital Abnormalities Perinatal Asphyxia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Esophageal Motility and Airway Defenses Among Infants

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Enrollment: 65
Study Start Date: May 2002
Study Completion Date: July 2005
Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)
Groups/Cohorts
A-1,2,3
The cohort (A) comprised of high risk infants. There were 3 sub groups studied within this cohort: (1) premature infants, (2) Infants with congenital gut anomalies, and (3) perinatal asphyxia.

Detailed Description:
With the aid of small clinical research funding from the NIDDK, in this proposal, we have developed methods to safely evaluate foregut motility in relation to breathing among high risk infants. We are using simultaneous esophageal motility studies, swallowing and respiratory measurements in this evaluation.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 6 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Premature infants congenital foregut anomalies Perinatal asphyxia
Criteria

Inclusion Criteria:

Prematurely born infants, Infants with congenital foregut anomalies, Infants with perinatal asphyxia, Ability to maintain vital signs at study,

Exclusion Criteria:

No contraindication to enteral feeding

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00062452


Locations
United States, Ohio
Columbus Childrens Hospital
Columbus, Ohio, United States, 43205
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Children's Research Institute
Investigators
Principal Investigator: Sudarshan R Jadcherla, MD Nationwide Children's Hospital/The Ohio State University College of Medicine
  More Information

Publications:
Responsible Party: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00062452     History of Changes
Other Study ID Numbers: EMADAI (completed)
R03DK061502 ( U.S. NIH Grant/Contract )
First Submitted: June 5, 2003
First Posted: June 6, 2003
Last Update Posted: October 6, 2017
Last Verified: January 2010

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Esophageal
Airway

Additional relevant MeSH terms:
Asphyxia
Infant, Premature, Diseases
Congenital Abnormalities
Death
Pathologic Processes
Wounds and Injuries
Infant, Newborn, Diseases